Lynn M. Bodarky

Corporate Officer/Principal at ACTINIUM PHARMACEUTICALS, INC.

58 year

Health Technology

Consumer Services

Profile

Lynn M.
Bodarky is currently the Chief Business Officer at Actinium Pharmaceuticals, Inc. Previously, she was the Vice President of Business Development at Geron Corp.
from 2019 to 2021 and the Vice President of Marketing at Progenics Pharmaceuticals, Inc. from 2004 to 2007.
She also held the position of Senior VP & Global Head of Business Development at HiFiBiO Inc. Ms. Bodarky has an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Wharton School of the University of Pennsylvania.

Lynn M. Bodarky active positions

Companies	Position	Start
ACTINIUM PHARMACEUTICALS, INC.	Corporate Officer/Principal	02/11/2023

All active positions of Lynn M. Bodarky

Former positions of Lynn M. Bodarky

Companies	Position	End
GERON CORPORATION	Corporate Officer/Principal	31/12/2020
PROGENICS PHARMACEUTICALS, INC.	Sales & Marketing	31/12/2006
HiFiBiO Inc. HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France.	Corporate Officer/Principal	-

See the detail of Lynn M. Bodarky's experience

Training of Lynn M. Bodarky

The Trustees of Columbia University in The City of New York	Masters Business Admin
The Wharton School of the University of Pennsylvania	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lynn M. Bodarky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
GERON CORPORATION	Health Technology
ACTINIUM PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Progenics Pharmaceuticals, Inc. Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY.	Health Technology
HiFiBiO Inc. HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France.	Health Technology